These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
151 related items for PubMed ID: 221579
1. The structural proteins of murine leukemia virus and the pathogenesis of necrotizing arteritis and glomerulonephritis in SL/Ni mice. Yoshiki T, Hayasaka T, Fukatsu R, Shirai T, Itoh T, Ikeda H, Katagiri M. J Immunol; 1979 May; 122(5):1812-20. PubMed ID: 221579 [No Abstract] [Full Text] [Related]
2. [C-type murine leukemia virus and the pathogenesis of necrotizing arteritis and glomerulonephritis in MRL/1 mice]. Hayasaka T. Hokkaido Igaku Zasshi; 1982 Nov; 57(6):688-95. PubMed ID: 6134659 [Abstract] [Full Text] [Related]
3. Specificity of cytolytic T cells directed against AKR/Gross virus-induced syngeneic leukemias: antibodies directed against H-2K, but not against viral proteins, inhibit lysis. Green WR, Nowinski RC, Henney CS. J Immunol; 1980 Aug; 125(2):647-55. PubMed ID: 6156211 [No Abstract] [Full Text] [Related]
4. Spontaneous necrotizing arteritis and glomerulonephritis in mice. Yoshiki T. Nihon Jinzo Gakkai Shi; 1981 Jul; 23(7):931-8. PubMed ID: 6275153 [No Abstract] [Full Text] [Related]
5. The GIX antigen of murine leukemia virus: an analysis with monoclonal antibodies. Pierotti M, DeLeo AB, Pinter A, O'Donnell PV, Hämmerling U, Fleissner E. Virology; 1981 Jul 30; 112(2):450-60. PubMed ID: 6167060 [No Abstract] [Full Text] [Related]
6. Immunopathogenicity and oncogenicity of murine leukemia viruses. II. Infection of mice and rats with Scripps leukemia virus. Del Villano BC, Croker BP, McConahey PJ, Dixon FJ. Am J Pathol; 1976 Feb 30; 82(2):299-314. PubMed ID: 175661 [Abstract] [Full Text] [Related]
7. Serological analysis of cell surface antigens of tumors induced by murine leukemia virus. Herberman RB. J Natl Cancer Inst; 1972 Jan 30; 48(1):265-71. PubMed ID: 4119883 [No Abstract] [Full Text] [Related]
8. Group-specific cytolytic antibody directed against the major glycoprotein (gp70) of murine leukemia viruses in serum of mice with dormant FLV infections. Callahan RM, Marx PA, Wheelock EF. Virology; 1979 Aug 30; 97(1):55-67. PubMed ID: 224581 [No Abstract] [Full Text] [Related]
9. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. III. Coordinate alterations in viral gp70 antigen expression and restoration of CTL-susceptibility to insusceptible variant tumors. Manjunath R, Graziano RF, Green WR. J Immunol; 1986 Mar 15; 136(6):2271-9. PubMed ID: 3005407 [Abstract] [Full Text] [Related]
10. Properties of mouse leukemia viruses. XVII. Factors required for successful treatment of spontaneous AKR leukemia by antibodies against gp71. Schwarz H, Ihle JN, Wecker E, Fischinger PJ, Thiel HJ, Bolognesi DP, Schäfer W. Virology; 1981 Jun 15; 111(2):568-78. PubMed ID: 6264673 [No Abstract] [Full Text] [Related]
11. Liposomes as a tool to study the role of membrane presentation in the immunogenicity of a MuLV-related tumor antigen. Gerlier D, Bakouche O, Dore JF. J Immunol; 1983 Jul 15; 131(1):485-90. PubMed ID: 6190925 [No Abstract] [Full Text] [Related]
12. Amplified expression of murine leukemia virus (MuLV)-coded antigens on thymocytes and leukemia cells of AKR mice after infection by dualtropic (MCF) MuLV. O'Donnell PV, Nowinski RC, Stockert E. Virology; 1982 Jun 15; 119(2):450-64. PubMed ID: 6177096 [No Abstract] [Full Text] [Related]
13. Clonal heterogeneity of anti-AKR/gross leukemia virus cytotoxic T lymphocytes. Evidence for two distinct antigen systems. Azuma H, Phillips JD, Green WR. J Immunol; 1987 Oct 01; 139(7):2464-73. PubMed ID: 2821116 [Abstract] [Full Text] [Related]
14. Natural immunity to endogenous oncornaviruses in mice. Ihle JN, Hanna MG. Contemp Top Immunobiol; 1977 Oct 01; 6():169-74. PubMed ID: 194747 [No Abstract] [Full Text] [Related]
15. Multiple antigens related to the major envelope glycoprotein of murine leukemia virus expressed on B16 melanoma cells as targets of host immune response. Stackpole CW, Demsey A. Invasion Metastasis; 1984 Oct 01; 4(1):28-46. PubMed ID: 6329988 [Abstract] [Full Text] [Related]
16. Expression of antigens coded in murine leukemia viruses on thymocytes of allogeneic donor origin in AKR mice following syngeneic or allogeneic bone marrow transplantation. Wustrow TP, Good RA. Cancer Res; 1985 Dec 01; 45(12 Pt 1):6428-35. PubMed ID: 2998600 [Abstract] [Full Text] [Related]
17. XenCSA: cell surface antigens related to the major glycoproteins (gp70) of xenotropic murine leukemia viruses. Morse HC, Chused TM, Boehm-Truitt M, Mathieson BJ, Sharrow SO, Hartley JW. J Immunol; 1979 Feb 01; 122(2):443-54. PubMed ID: 216748 [No Abstract] [Full Text] [Related]
18. Autogenous immunity to endogenous RNA tumor virus: virion and virus-induced cell surface antigens. Longstreth JD, Ihle JN, Hanna MG. Ann N Y Acad Sci; 1976 Feb 01; 276():343-57. PubMed ID: 68698 [No Abstract] [Full Text] [Related]
19. Serological Characterization of C-type retroviruses endogenous to the C57BL/6 mouse and isolated in tumours induced by radiation leukaemia virus (RadLV-Rs). Astier T, Guillemain B, Laigret F, Mamoun R, Duplan JF. J Gen Virol; 1982 Jul 01; 61 (Pt l)():55-63. PubMed ID: 6181187 [No Abstract] [Full Text] [Related]
20. Expression of CTL-defined, AKR/Gross retrovirus-associated tumor antigens by normal spleen cells: control by Fv-1, H-2, and proviral genes and effect on antiviral CTL generation. Green WR. J Immunol; 1986 Jan 01; 136(1):308-12. PubMed ID: 2999246 [Abstract] [Full Text] [Related] Page: [Next] [New Search]